comparemela.com

Latest Breaking News On - Medical oncology - Page 2 : comparemela.com

Dr Ahluwalia on the Incidence of Brain Metastases in RCC

Manmeet Ahluwalia, MD, MBA, FASCO, discusses findings from a National Cancer Database analysis on treatment outcomes of brain metastases from primary RCC.

Manmeet ahluwaliaBaptist health miami cancer instituteNational cancer databaseCancer researchMedical oncologyFernandez family endowed chair

Insomnia Loss Can Raise Risk Of Ovarian Cancer, Impact Survival — Experts

Insomnia Loss Can Raise Risk Of Ovarian Cancer, Impact Survival — Experts
easternmirrornagaland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from easternmirrornagaland.com Daily Mail and Mail on Sunday newspapers.

Tamil naduKinjal kothariCancer instituteAssociate consultantManipal hospitalConsultant surgical oncologySenior consultantMedical oncology

Dr Gadi on Results From of the DESTINY-Breast06 Trial in HR+/HER2-Low Breast Cancer

VK Gadi, MD, PhD, discusses primary results from the phase 3 DESTINY-Breast06 trial of trastuzumab deruxtecan in HR-positive, HER2-low breast cancer.

Department of medicineUniversity of illinois college medicine chicagoDivision of hematology oncologyUniversity of illinois cancer centerIllinois cancer centerMedical oncologyIllinois collegeMedicine chicago

Dr Pegram on the Implications and Safety of T-DXd in HR+/HER2-Low and -Ultralow Breast Cancer

Dr Pegram on the Implications and Safety of T-DXd in HR+/HER2-Low and -Ultralow Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Mark pegramStanford comprehensive cancer instituteStanford clinical translational research unitClinical researchSuzy yuan huey hung endowed professorMedical oncologyClinical research qualityStanford university school

Notable RCC Data Presented at ASCO May Shed Light on Key Biomarkers and Combination Approaches

Benjamin L. Maughan, MD, PharmD, dives into key studies in RCC regarding biomarkers and first-line treatments presented at the 2024 ASCO Annual Meeting

United statesBenjaminl maughanMedical oncologyHuntsman cancer instituteSalt lake city

vimarsana © 2020. All Rights Reserved.